Micro-volume wall-less immunoassays using patterned planar plates.

Miniaturization of immunoassays has numerous potential advantages over traditional ELISAs. Here we present a novel approach using patterned planar plates (PPPs). These 'wall-less' plates consist of a 16 × 24 array of 2 mm diameter hydrophilic regions surrounded by a hydrophobic polytetrafluoroethylene (PTFE) coating. Assays are performed by adding 2 μL droplets to the hydrophilic areas. These droplets are overlaid with an immiscible mixture of perfluorocarbon liquid (PFCL) that essentially eliminates evaporation. During wash steps, a thin film of PFCL covers the hydrophobic coating and prevents its wetting by wash buffer; as a result, the hydrophilic wells remain intact and inter-well cross-contamination is prevented. We compared the performance of three immunoassays using PPPs versus traditional 384-well ELISA plates. These included assays for soluble FcRH5 in human serum, SDF-1 in mouse serum, and human IgG in mouse plasma. The results show that the PPP assays were closely comparable to the ELISAs in terms of sensitivity, linearity of dilution, and sample quantitation. Moreover, the PPP assays were rapid to perform, easily adapted from ELISA protocols, and used 10- to 50-fold less sample and reagent volume as compared to 384- or 96-well plate ELISAs. As an additional advantage, PPPs conform to established microplate dimensional standards making them compatible with pre-existing equipment and workflows. PPPs therefore represent an attractive and broadly applicable approach to flexible miniaturization of plate-based immunochemical assays.

[1]  S. Kingsmore Multiplexed protein measurement: technologies and applications of protein and antibody arrays , 2006, Nature Reviews Drug Discovery.

[2]  Ryan Okon,et al.  Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. , 2004, Clinical chemistry.

[3]  Thomas H. Shaffer,et al.  Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress Syndrome , 1996 .

[4]  E. Engvall,et al.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. , 1971, Immunochemistry.

[5]  H. Busch,et al.  Safety and feasibility of nasopharyngeal evaporative cooling in the emergency department setting in survivors of cardiac arrest. , 2010, Resuscitation.

[6]  W. Zou,et al.  Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. , 2007, American journal of physiology. Cell physiology.

[7]  M. Gerstein,et al.  Analysis of yeast protein kinases using protein chips , 2000, Nature Genetics.

[8]  W. Wilson,et al.  Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma , 2007, Leukemia.

[9]  J. Ying,et al.  Recyclable hydrophilic-hydrophobic micropatterns on glass for microarray applications. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[10]  J. Ying,et al.  Elucidating drug resistance properties in scarce cancer stem cells using droplet microarray , 2012 .

[11]  G. Whitesides The origins and the future of microfluidics , 2006, Nature.

[12]  Qian Chen,et al.  Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. , 2004, The Journal of bone and joint surgery. British volume.

[13]  R. Ekins,et al.  Ligand assays: from electrophoresis to miniaturized microarrays. , 1998, Clinical chemistry.

[14]  Christoph A. Merten,et al.  Miniaturization and parallelization of biological and chemical assays in microfluidic devices. , 2010, Chemistry & biology.

[15]  Pingbo Zhang,et al.  Multiplex assays for biomarker research and clinical application: Translational science coming of age , 2010, Proteomics. Clinical applications.

[16]  M. Sormani,et al.  CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. , 2009, European journal of cancer.

[17]  Se Young Oh,et al.  In situ electrochemical enzyme immunoassay on a microchip with surface-functionalized poly(dimethylsiloxane) channel , 2006 .

[18]  George G Klee,et al.  Antibody-based protein multiplex platforms: technical and operational challenges. , 2010, Clinical chemistry.

[19]  Scott L Diamond,et al.  Printing chemical libraries on microarrays for fluid phase nanoliter reactions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Mirzabekov,et al.  Protein microchips: use for immunoassay and enzymatic reactions. , 2000, Analytical biochemistry.

[21]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[22]  Roger D Kamm,et al.  A high-throughput microfluidic assay to study neurite response to growth factor gradients. , 2011, Lab on a chip.

[23]  Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera , 2006, Clinical chemistry and laboratory medicine.

[24]  Yoon‐Kyoung Cho,et al.  A fully automated immunoassay from whole blood on a disc. , 2009, Lab on a chip.

[25]  S. Robson,et al.  Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. , 2006, Journal of immunological methods.

[26]  Aaron R Wheeler,et al.  Immunoassays in microfluidic systems , 2010, Analytical and bioanalytical chemistry.

[27]  R. Zengerle,et al.  Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. , 2010, Chemical Society reviews.

[28]  Christian Pfleger,et al.  Effect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays. , 2008, Journal of immunological methods.

[29]  Hiroyuki Fujita,et al.  Microfabricated arrays of femtoliter chambers allow single molecule enzymology , 2005, Nature Biotechnology.

[30]  N. Palanisamy,et al.  IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. , 2001, Immunity.